CompletedNot Applicable

Comparison of H-FIRE and TURP in Treating Benign Prostatic Hyperplasia

China118 participantsStarted 2022-06-30

Plain-language summary

This trial is comparing the effects and safety in treating men with benign prostatic hyperplasia between high freqnence irreversible electroporation and trans urethral resection prostate.

Who can participate

Age range40 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age over 40 years old
✓. IPSS\>8
✓. Qmax \<15ml/s
✓. Prostatic volume range of 30 to 100ml, measured by MRI
✓. Fully understand the clinical trial protocol and sign the informed consent

What they're measuring

maximum urinary flow rate(Qmax)

Timeframe: 3 months after surgical treatment

urination function(evaluated by International prostate symptom score, IPSS)

Timeframe: 3 months after surgical treatment

Trial details

NCT IDNCT05306145

SponsorShanghai East Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-25

View on ClinicalTrials.gov More Benign Prostatic Hyperplasia trials